Option Care Health Inc's stock plummeted 30.98% during intraday trading on Thursday, following the release of its first-quarter 2026 financial results.
The US infusion services provider reported Q1 revenue of $1.35 billion, which missed analyst expectations of $1.40 billion. Revenue grew only 1.3% year-over-year, a pace the company's CEO described as unsatisfactory, noting the quarter represented a "mixed performance." Furthermore, the company's full-year 2026 revenue guidance range of $5.68 billion to $5.78 billion fell significantly below the FactSet consensus estimate of $5.94 billion.
While the company's Q1 adjusted EBITDA of $104.8 million slightly exceeded estimates and its full-year adjusted EPS guidance was roughly in line with expectations, the substantial revenue shortfall and lowered outlook for the year were the primary drivers behind the sharp sell-off in the stock.
Comments